These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35981656)
1. FOXO1 differentially regulates bone formation in young and aged mice. Xiong Y; Zhang Y; Zhou F; Liu Y; Yi Z; Gong P; Wu Y Cell Signal; 2022 Nov; 99():110438. PubMed ID: 35981656 [TBL] [Abstract][Full Text] [Related]
2. FoxO1 expression in osteoblasts modulates bone formation through resistance to oxidative stress in mice. Zhang Y; Xiong Y; Zhou J; Xin N; Zhu Z; Wu Y Biochem Biophys Res Commun; 2018 Sep; 503(3):1401-1408. PubMed ID: 30025894 [TBL] [Abstract][Full Text] [Related]
4. FOXOs attenuate bone formation by suppressing Wnt signaling. Iyer S; Ambrogini E; Bartell SM; Han L; Roberson PK; de Cabo R; Jilka RL; Weinstein RS; O'Brien CA; Manolagas SC; Almeida M J Clin Invest; 2013 Aug; 123(8):3409-19. PubMed ID: 23867625 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice. Jiang Y; Luo W; Wang B; Wang X; Gong P; Xiong Y Life Sci; 2020 Apr; 246():117422. PubMed ID: 32057903 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. Almeida M; Han L; Martin-Millan M; O'Brien CA; Manolagas SC J Biol Chem; 2007 Sep; 282(37):27298-27305. PubMed ID: 17623658 [TBL] [Abstract][Full Text] [Related]
7. Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathway. Li L; Li A; Zhu L; Gan L; Zuo L J Orthop Surg Res; 2022 May; 17(1):286. PubMed ID: 35597989 [TBL] [Abstract][Full Text] [Related]
8. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396 [TBL] [Abstract][Full Text] [Related]
9. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss. Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979 [TBL] [Abstract][Full Text] [Related]
10. TNF-α Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis. Liao L; Su X; Yang X; Hu C; Li B; Lv Y; Shuai Y; Jing H; Deng Z; Jin Y Stem Cells; 2016 Apr; 34(4):1054-67. PubMed ID: 26700816 [TBL] [Abstract][Full Text] [Related]
11. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss. Hong G; He X; Shen Y; Chen X; Yang F; Yang P; Pang F; Han X; He W; Wei Q Stem Cell Res Ther; 2019 Aug; 10(1):277. PubMed ID: 31464653 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of SIRT1 inhibits H2O2‑induced osteoblast apoptosis via FoxO1/β‑catenin pathway. Yao H; Yao Z; Zhang S; Zhang W; Zhou W Mol Med Rep; 2018 May; 17(5):6681-6690. PubMed ID: 29512706 [TBL] [Abstract][Full Text] [Related]
13. Kaempferide enhances antioxidant capacity to promote osteogenesis through FoxO1/β-catenin signaling pathway. Ma X; Tian Y; Xue K; Huai Y; Patil S; Deng X; Hao Q; Li D; Miao Z; Zhang W; Qian A Eur J Pharmacol; 2021 Nov; 911():174555. PubMed ID: 34627807 [TBL] [Abstract][Full Text] [Related]
14. Lipoteichoic acid restrains macrophage senescence via β-catenin/FOXO1/REDD1 pathway in age-related osteoporosis. Cheng W; Fu Y; Lin Z; Huang M; Chen Y; Hu Y; Lin Q; Yu B; Liu G Aging Cell; 2024 Mar; 23(3):e14072. PubMed ID: 38126583 [TBL] [Abstract][Full Text] [Related]
15. MiR-184 targeting FOXO1 regulates host-cell oxidative stress induced by Chen L; Huang Q; Luo Y; Zhou Y; Tong T; Chen Y; Bai Q; Lu C; Li Z Infect Immun; 2023 Nov; 91(11):e0033723. PubMed ID: 37815369 [No Abstract] [Full Text] [Related]
16. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Rached MT; Kode A; Xu L; Yoshikawa Y; Paik JH; Depinho RA; Kousteni S Cell Metab; 2010 Feb; 11(2):147-60. PubMed ID: 20142102 [TBL] [Abstract][Full Text] [Related]
17. Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer. Xu S; Shi Y; Li S Cancer Chemother Pharmacol; 2024 Mar; 93(3):191-202. PubMed ID: 38051377 [TBL] [Abstract][Full Text] [Related]
18. 1α,25-Dihydroxyvitamin D Xiong Y; Zhang Y; Xin N; Yuan Y; Zhang Q; Gong P; Wu Y J Biol Chem; 2017 Dec; 292(49):20270-20280. PubMed ID: 29042442 [TBL] [Abstract][Full Text] [Related]
19. Perturbed differentiation of murine embryonic stem cells upon Pelota deletion due to dysregulated FOXO1/β-catenin signaling. Elkenani M; Nyamsuren G; Toischer K; Adham IM; Mohamed BA FEBS J; 2021 May; 288(10):3317-3329. PubMed ID: 33245852 [TBL] [Abstract][Full Text] [Related]
20. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Manolagas SC; Almeida M Mol Endocrinol; 2007 Nov; 21(11):2605-14. PubMed ID: 17622581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]